The first comprehensive handbook entirely dedicated to all the aspects of antiplatelet therapy, this work surveys pathophysiology, pharmacology and therapy. Coverage incorporates recent achievements, and includes current and novel antiplatelet agents and more.

Antiplatelet therapy is the cornerstone of treatment of ischemic cardiovascular disease and over the last few years spectacular advancements in this field have been recorded. This is the first comprehensive handbook entirely dedicated to all the aspects of antiplatelet therapy. The book is divided into three main sections, pathophysiology, pharmacology and therapy, for a total of 23 chapters. A large group of leading experts from different European countries and from the USA, both from academia and industry, have contributed to the book. Besides a detailed overview on the pharmacology and clinical applications of all the currently used or of the novel antiplatelet agents, innovative approaches (e.g. intracellular signalling as an antiplatelet target, small RNAs as platelet therapeutics, etc.) or unconventional aspects (e.g. pharmacologic modulation of the inflammatory action of platelets are also treated. The book is oriented to both basic investigators and to clinicians involved with research on platelet inhibition or with the clinical use of antiplatelet therapies.

Written by leading experts in the field With numerous illustrations Gives an overview on the current state of the art Includes supplementary material: sn.pub/extras

Inhalt

Foreword .- Preface.- Part 1. Pathophysiology.- Part 2. Pharmacology.- Part 3. Therapy.